Tirasemtiv

N/A

Report date: 2023/10/26 20:01:00
NME

Base Information

Drug NameTirasemtiv
Drug Alias Name泰拉生替Tirasemtivum泰雷森替CK-357CK-2017357
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFast skeletal troponin complex activatorsTroponin tropomyosin complex stimulants
TargetsTroponin tropomyosin complexFast skeletal troponin complex
Therapy Area/IndicationsIntermittent ClaudicationPeripheral Arterial DiseaseAmyotrophic Lateral Sclerosis +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[11] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCytokinetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma IncCytokinetics Inc
Active IndicationsN/A
Inactive IndicationsIntermittent ClaudicationPeripheral Arterial DiseaseAmyotrophic Lateral Sclerosis +[4] 

Other Information

ATC CodeN/A
Related LinksKEGG